Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Chen, Eddy J EJ; Sowalsky, Adam G AG; Gao, Shuai S; Cai, Changmeng C; Voznesensky, Olga O; Schaefer, Rachel R; Loda, Massimo M; True, Lawrence D LD; Ye, Huihui H; Troncoso, Patricia P; Lis, Rosina L RL; Kantoff, Philip W PW; Montgomery, Robert B RB; Nelson, Peter S PS; Bubley, Glenn J GJ; Balk, Steven P SP; Taplin, Mary-Ellen ME